A Biomarker Study to Evaluate MN-166 (Ibudilast) in Subjects With Amyotrophic Literal Sclerosis (ALS)

Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Drug: ibudilast
Sponsors:   MediciNova;   Massachusetts General Hospital;   South Shore Neurologic Associates
Recruiting - verified February 2017